$ Value
$0
Shares
86,250
Price
$0
Filed
Feb 10
Insider
Name
Sandrock Alfred
Title
President and CEO
CIK
0001577061
Roles
Transaction Details
Transaction Date
2026-02-06
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
522,181
Footnotes
Consists of shares of common stock issuable under an aggregate of 86,250 restricted stock units ("RSUs") awarded to the Reporting Person pursuant to the Voyager Therapeutics, Inc. 2025 Stock Incentive Plan (the "Plan"). Each RSU represents the right to receive one share of common stock upon vesting. The vesting commencement date of the RSU award is the grant date, February 6, 2026. The RSU award vests over three years, with 1/3rd of the shares of common stock underlying the RSU award vesting on the one-year anniversary of such vesting commencement date and an additional 1/3rd of the shares of common stock underlying the RSU award vesting at the end of each successive one-year period thereafter, subject to the Reporting Person's continued service. | Includes 5,000 shares of common stock acquired under the Voyager Therapeutics, Inc. Amended and Restated 2015 Employee Stock Purchase Plan since the date of the reporting person's last Form 4. | This stock option was issued pursuant to the Plan. The vesting commencement date of the option is the grant date, February 6, 2026. The option vests over four years, with 1/48th of the shares of common stock underlying the option vesting upon the one-month anniversary of such vesting commencement date and an additional 1/48th of the shares of common stock underlying the option vesting at the end of each successive one-month period thereafter, subject to the Reporting Person's continued service.
Filing Info
Sandrock Alfred's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-02 | VYGR | ▼ | $45K |
| 2026-02-24 | VYGR | ▼ | $54K |
| 2026-02-18 | VYGR | ▼ | $40K |
| 2026-02-10 | VYGR | ▼ | $46K |
| 2026-02-06 | VYGR | A | $0 |
| 2026-02-06 | VYGR | A | $0 |
Other Insiders at VYGR (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Sandrock Alfred
President and CEO
|
— | $184K | 2026-04-02 |
|
Jorgensen Nathan D.
Chief Financial Officer
|
— | $18K | 2026-02-24 |
|
Swartz Robin
COO & CBO
|
— | $55K | 2026-02-24 |
|
Carter Todd Alfred
Chief Scientific Officer
|
— | $41K | 2026-02-24 |
|
Ferguson Toby
Chief Medical Officer
|
— | — | 2026-02-06 |
|
Shiferman Gregory L.
SVP and General Counsel
|
— | — | 2026-04-01 |